Channabasappa Shivaprasad1, Kolla Gautham2, Kejal Shah3, Soumya Gupta3, Preethika Palani3, Biswas Anupam2. 1. Department of Endocrinology, Sapthagiri Institute of Medical Sciences and Research Centre (SIMS&RC), Bangalore, India. 2. Department of Endocrinology, Vydehi Institute of Medical Sciences and Research Centre (VIMS&RC), Bangalore, India. 3. Department of Internal Medicine, Vydehi Institute of Medical Sciences and Research Centre, Bangalore, India.
Abstract
BACKGROUND: Detailed evaluations of hypoglycemia and associated indices based on continuous glucose monitoring (CGM) are limited in patients with diabetes of the exocrine pancreas. Our study sought to evaluate the frequency and pattern of hypoglycemic events and to investigate hypoglycemia-specific indices in this population. METHODS: This was a cross-sectional study comprising 83 participants with diabetes of the exocrine pancreas. CGM and self-monitoring of blood glucose (SMBG) were performed on all participants for a minimum period of 72 hours. The frequency and pattern of hypoglycemic events, as well as hypoglycemia-related indices, were evaluated. RESULTS: Hypoglycemia was detected in 90.4% of patients using CGM and 38.5% of patients using SMBG. Nocturnal hypoglycemic events were more frequent (1.9 episodes/patient) and prolonged (142 minutes) compared with day-time events (1.1 episodes/patient; 82.8 minutes, P < 0.05). The mean low blood glucose index was 2.1, and glycemic risk assessment diabetes equation hypoglycemia was 9.1%. The mean time spent below (TSB) <70 mg/dL was 9.2%, and TSB <54 mg/dL was 3.7%. The mean area under curve (AUC) <70 mg/dL was 1.7 ± 2.5 mg/dL/hour and AUC <54 mg/dL was 0.6 ± 1.3 mg/dL/hour. All of the CGM-derived hypoglycemic indices were significantly more deranged at night compared with during the day (P < 0.05). CONCLUSION: Patients with diabetes of the exocrine pancreas have a high frequency of hypoglycemic episodes that are predominantly nocturnal. CGM is superior to SMBG in the detection of nocturnal and asymptomatic hypoglycemic episodes. CGM-derived hypoglycemic indices are beneficial in estimating the risk of hypoglycemia.
BACKGROUND: Detailed evaluations of hypoglycemia and associated indices based on continuous glucose monitoring (CGM) are limited in patients with diabetes of the exocrine pancreas. Our study sought to evaluate the frequency and pattern of hypoglycemic events and to investigate hypoglycemia-specific indices in this population. METHODS: This was a cross-sectional study comprising 83 participants with diabetes of the exocrine pancreas. CGM and self-monitoring of blood glucose (SMBG) were performed on all participants for a minimum period of 72 hours. The frequency and pattern of hypoglycemic events, as well as hypoglycemia-related indices, were evaluated. RESULTS: Hypoglycemia was detected in 90.4% of patients using CGM and 38.5% of patients using SMBG. Nocturnal hypoglycemic events were more frequent (1.9 episodes/patient) and prolonged (142 minutes) compared with day-time events (1.1 episodes/patient; 82.8 minutes, P < 0.05). The mean low blood glucose index was 2.1, and glycemic risk assessment diabetes equation hypoglycemia was 9.1%. The mean time spent below (TSB) <70 mg/dL was 9.2%, and TSB <54 mg/dL was 3.7%. The mean area under curve (AUC) <70 mg/dL was 1.7 ± 2.5 mg/dL/hour and AUC <54 mg/dL was 0.6 ± 1.3 mg/dL/hour. All of the CGM-derived hypoglycemic indices were significantly more deranged at night compared with during the day (P < 0.05). CONCLUSION: Patients with diabetes of the exocrine pancreas have a high frequency of hypoglycemic episodes that are predominantly nocturnal. CGM is superior to SMBG in the detection of nocturnal and asymptomatic hypoglycemic episodes. CGM-derived hypoglycemic indices are beneficial in estimating the risk of hypoglycemia.
Entities:
Keywords:
continuous glucose monitoring; diabetes of the exocrine pancreas; hypoglycemia; hypoglycemic indices
Authors: Ajay K Parsaik; Mohammad Hassan Murad; Airani Sathananthan; Vetriselvi Moorthy; Patricia J Erwin; Suresh Chari; Rickey E Carter; Michael B Farnell; S S Vege; Michael G Sarr; Yogish C Kudva Journal: Clin Endocrinol (Oxf) Date: 2010-12 Impact factor: 3.478
Authors: Laith H Jamil; Ana M Chindris; Kanwar R S Gill; Daniela Scimeca; John A Stauffer; Michael G Heckman; Shon E Meek; Justin H Nguyen; Horacio J Asbun; Massimo Raimondo; Timothy A Woodward; Michael B Wallace Journal: HPB Surg Date: 2012-08-26
Authors: Allan L Reiss; Booil Jo; Ana Maria Arbelaez; Eva Tsalikian; Bruce Buckingham; Stuart A Weinzimer; Larry A Fox; Allison Cato; Neil H White; Michael Tansey; Tandy Aye; William Tamborlane; Kimberly Englert; John Lum; Paul Mazaika; Lara Foland-Ross; Matthew Marzelli; Nelly Mauras Journal: Nat Commun Date: 2022-08-30 Impact factor: 17.694